OEM and ODM describe two different ways to source pet care production, and the contract you sign decides who controls the formula, the tooling and your brand assets long after the first order ships. Most sourcing disputes are not about quality; they are about ownership that was never written down. This guide breaks down the ownership, confidentiality, exclusivity and exit clauses that export brands should settle before a purchase order, and how to test which model your differentiation strategy can actually support.
Four Sourcing Models, Not Two
The OEM versus ODM shorthand hides two intermediate positions that most brands actually occupy. In a pure ODM engagement the manufacturer supplies a proven base formula, you choose the pack and the brand, and the formula intellectual property stays with the supplier. In a pure OEM engagement you bring a finished or near-finished formula that the factory executes to your specification, and you normally retain ownership of it. Between them sit an ODM base with a documented custom twist, and a joint development where the factory formulates to your brief but you fund and own the result.
The commercial difference is where the development cost sits. ODM amortises formula development across several clients, which is why it supports a low entry volume and a fast launch. OEM and joint development concentrate cost on you, which is why they support differentiation and a defensible margin. Neither is superior; the mistake is choosing ODM for speed and then expecting OEM-level exclusivity from the contract.
| Model | Who develops the formula | Who owns the base formula | Typical entry | Best fit |
|---|---|---|---|---|
| Standard ODM / private label | Manufacturer, from an existing catalogue base | Manufacturer | Standard ODM minimum, 1,000 pieces per SKU | Fast launch, validated category, brand-led marketing |
| ODM with documented custom twist | Manufacturer, adjusting an existing base to your brief | Manufacturer owns the base; the agreed twist is defined in the contract | Minimum plus development fee | Moderate differentiation without a lab |
| OEM to your formula | You, with the factory providing process support | You | Higher minimum, confidentiality-heavy contract | Proprietary actives, patents, regulated claims |
| Joint development | Both, against a funded brief | Negotiated - must be stated per deliverable | Development fee plus minimum commitment | Category creation, long-horizon brand platforms |
Source: author's framework for pet care sourcing structures; ISO 22716:2007 as the process baseline common to all four models.
What "Owning the Formula" Actually Means
Formula ownership is not a feeling about who had the idea. It is a bundle of rights: the right to the complete manufacturing document, the right to have another party make the product, the right to control disclosure, and the right to stop others using it. In a standard ODM relationship you typically receive a product specification and a certificate of analysis, not the manufacturing document, and you may hold a licence to sell rather than any right to transfer production.
Test the position with three questions before you sign. Can you obtain the full formula and process document if the relationship ends, and at what cost? Can you have the same product manufactured elsewhere, and does the contract permit it? And is the base formula also supplied to other clients in your category and your region? The third question is the one brands forget, and it is the one that determines whether your differentiation is real or cosmetic.
There is a legitimate middle ground: define a specific, documented variant - a different active level, a different carrier, an added functional ingredient - and give that variant its own ownership and non-supply clause. That preserves the low entry cost of an ODM base while creating something a competitor cannot buy off the shelf, provided the variant is described precisely enough in an annex to be enforceable.
- Does the contract transfer the manufacturing document, or only a specification?
- Can production be transferred to another qualified site, and on what notice?
- Is the base formula supplied to competitors in the same market?
- Is the custom variant described precisely enough in an annex to be enforced?
- Who owns improvements made after launch - and who pays for them?
Tooling, Artwork and Brand Assets
Tooling is property, and property needs a name on it. Moulds, printing plates, screen frames, embossing cylinders and filling nozzles are frequently charged to the brand but held physically at the factory, which creates an ambiguous position at the end of a relationship. The contract should identify each item, state who owns it, where it is stored, who maintains it and what happens on termination - including a right to collect it or be compensated for it.
Brand assets are simpler in principle and still need stating. Your name, logo, artwork and product photography are your intellectual property regardless of the sourcing model, and the contract should confirm that the supplier holds no licence to use them beyond fulfilling your orders, will not display your packaging in a portfolio without written consent, and will delete or return artwork files on request. The last point matters more than it appears: unreturned artwork is how a private label design reappears on another brand's shelf.
Where a supplier creates artwork or photography for you, the assignment of rights should be explicit and complete, including the right to modify. Where they create a pack structure or a dispenser configuration, treat it as tooling rather than design.
NDAs, Trade Secrets and the Duty You Owe Yourself
A confidentiality agreement is necessary and not sufficient. In the EU, trade secret protection under Directive (EU) 2016/943 depends on the information being secret, having commercial value because it is secret, and being subject to reasonable steps to keep it secret. That third limb is the one brands neglect. If the formula is emailed to six people, stored in a shared folder with open access, or discussed in a meeting with a third-party contractor who has signed nothing, the reasonable-steps test becomes hard to satisfy.
Draft for the specific information you are actually disclosing: formula and process parameters, specification limits, supplier identities, stability data, COA templates and commercial terms. Include carve-outs for information that is already public, independently developed or required to be disclosed by law, because an NDA with no carve-outs is difficult to enforce and invites a blanket refusal. Set a defined term - three to five years is common, with trade secrets surviving for as long as they remain secret - and require the return or destruction of documents and samples on termination.
For export brands, add two clauses that rarely appear in templates. First, that the supplier will not disclose your formulation or your identity to distributors, customers or regulators beyond what the law requires, and will notify you when disclosure is compelled. Second, that the supplier declares its sub-suppliers and contract manufacturers, and flows equivalent obligations to them. A secret shared with an undeclared sub-supplier is not a secret.
Exclusivity Only Works With a Volume Floor
Exclusivity is the clause most often requested and least often enforced, because a promise not to sell to others without a commitment to buy is a one-sided obligation that a supplier will either refuse or quietly ignore. Make it mutual and measurable: a defined geography, a defined SKU scope, a defined channel, and a minimum annual volume or spend that keeps the exclusivity in force.
Define the failure mode too. If the volume floor is missed, does exclusivity lapse automatically, convert to non-exclusive, or become renegotiable? Each answer changes behaviour differently. An automatic lapse is simple to administer; a renegotiation window preserves the relationship. What does not work is silence, which produces a dispute at the exact moment the brand's growth is being constrained by the supplier's other clients.
| Clause | What to specify | How it fails when left vague |
|---|---|---|
| Formula ownership | Named owner per deliverable, document handover list, transfer fee if any | Brand discovers it licences a spec and cannot move production |
| Confidentiality | Defined information categories, term, carve-outs, sub-supplier flow-down, compelled-disclosure notice | Trade secret status is contested for lack of reasonable steps |
| Tooling | Item list, owner, storage location, maintenance, collection or compensation on exit | Tooling is stranded at a site the brand no longer works with |
| Exclusivity | Geography, SKU and channel scope, minimum annual volume, lapse mechanism | Exclusivity is unenforceable or silently ignored |
| Change notification | Notice period for formula, material, pack or site changes; right to approve or exit | A silent substitution invalidates stability data and label claims |
| Exit and transition | Notice period, final order rights, remaining stock, retained samples, document return | Launch continuity breaks and stock is stranded mid-season |
Source: author's contract clause framework; Directive (EU) 2016/943 on the protection of undisclosed know-how and business information.
Regulatory Identity: Who Is the Manufacturer in Law
Ownership questions are commercial; regulatory identity is statutory, and the two are not the same. Under the EU General Product Safety Regulation (EU) 2023/988, the manufacturer is the party that manufactures the product, has it designed or manufactured, or markets it under its own name or trade mark. A brand selling a private label pet product under its own name is therefore the manufacturer for the purposes of the regulation, whatever the contract says about who owns the formula.
That has a direct contractual consequence: you need the right to the documentation that proves safety - the technical file, the risk assessment, the test reports, the batch traceability - not merely the right to sell the product. Add a clause requiring the supplier to provide and maintain that file, to notify you of any safety-related change or incident, and to support a recall or withdrawal within a stated time. Our manufacturer due diligence framework sets out the evidence to request at qualification, before these obligations become urgent.
Choosing the Model Against Your Differentiation Strategy
Decide the model from the answer to one question: is your advantage the product or the brand? If the advantage is brand - positioning, content, community, channel - an ODM base is rational, because the formula is not the thing you are defending and speed to market is worth more than exclusivity. Invest the saving in packaging, content and distribution instead.
If the advantage is the product - a proprietary active, a novel delivery format, a clinical or veterinary positioning - then OEM or joint development is the only coherent choice, and the contract has to protect the asset that creates the margin. Budget for development time, for a confidentiality regime you actually operate, and for a second manufacturing source qualified before you need it.
Most brands sit in the middle for their first launch and move toward OEM as they grow. That progression is fine as long as it is planned: our custom formula roadmap sequences a move from an ODM base to an owned formula without a relaunch, and our factory audit checklist covers what to verify at the site that will make it. If you would rather talk the clause structure through with the team that will sign it, contact us before the first purchase order rather than after.
Frequently Asked Questions
In an ODM arrangement, who owns the formula?
Typically the manufacturer. An ODM base formula is developed and amortised across several clients, so the supplier retains the manufacturing document and grants you the right to sell product made to it under your brand. You generally receive a specification and a certificate of analysis, not the full process document. If you need the right to transfer production, negotiate that explicitly, because it is not implied by buying the product.
Can I get exclusivity on an ODM formula?
You can, but expect to pay for it through a volume floor rather than a fee. Exclusivity without a minimum annual commitment is a one-sided promise and is usually either refused or ignored. Specify the geography, the SKU and channel scope, and the volume or spend that keeps it alive, then state what happens if the floor is missed - automatic lapse is the simplest mechanism to administer.
How long should an NDA last for a formula?
Three to five years is common for commercial information, with trade secrets protected for as long as they remain secret. What matters more than the term is the scope: name the categories of information you are disclosing, include carve-outs for public, independently developed and legally compelled information, and require return or destruction of documents and samples. An NDA that the supplier cannot realistically comply with is weaker than a narrow one that is actually operated.
Who owns the mould if I pay for it?
You should, and the contract should say so explicitly, together with where the tooling is stored, who maintains it and what happens on termination. Many brands pay a tooling fee and leave ownership unstated, which becomes a problem when they want to move the SKU. If the fee is amortised into the unit price instead, the agreement should state the amortisation volume and what happens to the balance if that volume is not reached.
Am I the legal manufacturer if I sell under my own brand?
In the EU, under the General Product Safety Regulation (EU) 2023/988, a party that markets a product under its own name or trade mark is treated as the manufacturer. That is a statutory identity independent of who owns the formula, and it brings duties to hold the technical documentation and to act on safety issues. The contract therefore needs to guarantee your access to the technical file, test reports and batch traceability, and to require notification of safety-relevant changes.
What should an exit clause include?
A notice period, a final order right, treatment of remaining stock and open orders, return or destruction of your artwork and documents, collection or compensation for your tooling, and a defined transition window during which the supplier continues to supply. Also require retained samples and the specification package, so a new site can match the product. Brands that skip this end up relaunching rather than transferring, which costs far more than the clause.
Conclusion
OEM and ODM are not better or worse; they trade control against speed and cost, and the contract is where that trade is recorded. Put formula ownership, the documentation handover, tooling title, trademark limits, exclusivity with a volume floor, and exit mechanics in writing before the first purchase order. Then check that the agreement matches your regulatory identity as the party marketing the product under its own name, because that identity is statutory and survives whatever the commercial clauses say. A sourcing contract is not a formality that follows the commercial deal; it is the part of the deal that still exists when the relationship changes, and the only part that protects the brand when it does.
